• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

MicroTransponder completes $3.4M in funding, gets key patent
Dallas-based MicroTransponder Inc., a privately-held medical device company, has completed a $3.39 million funding round this summer, which will enable the company to accelerate development of its wireless pain platform. The funding will allow MicroTransponder to complete three additional clinical trials using its neurostimulation system to treat both stroke patients and tinnitus patients, Jordan Curnes, co-founder, president and chief operating officer, told me. Tinnitus is the medical term for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research

Tau Imaging Among Breakthroughs Advancing the Fight against Alzheimer ' s
Worldwide,  nearly44 million  people now have Alzheimer ' s disease (AD) or related dementia, making these conditions the  top cause of disabilities in later life. The biopharma industry has invested billions of dollars into research to treat and prevent AD1, yet this work has faced many obstacles, including difficulty identifying biomarkers, tracking the disease ’s progress in the brain, and recruiting patients to trials while they are still asymptomatic. But in recent years, we’ve begun to see breakthroughs that is driving our research in new directions. Many of these accomplishments were highlighted at the Alzh...
Source: EyeForPharma - September 21, 2016 Category: Pharmaceuticals Authors: Olga Uspenskaya-Cadoz Source Type: news